ArticleDermatologie (Heidelberg, Germany)2023

[Low-dose topical recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) therapy for chronic venous leg ulcers, 10-year follow-up].

Erna Jaschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.